The current viral vector characterization landscape: from navigating evolving regulatory guidance to leveraging analytical tools for process development

“Peering into the future a decade from now, there is an expectation of significant regulatory evolution in the realm of viral vector development, foreseeing the development of evolving guidelines and increased flexibility in response to emerging technologies and novel therapeutic approaches.”

Please enter your email to access content Read now